Vertex Pharmaceuticals Inc (VRTX) — Free Cash Flow Generation Index
Vertex Pharmaceuticals Inc (VRTX) has a Free Cash Flow Generation Index of 0.91x as of March 2026. Free cash flow of $1.29 Billion represents 1% of operating cash flow ($1.43 Billion). See VRTX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Vertex Pharmaceuticals Inc Free Cash Flow Generation Index (1993–2025)
Historical FCF Generation Index trend for Vertex Pharmaceuticals Inc across 12 annual periods. Explore VRTX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year Free Cash Flow Generation Index for Vertex Pharmaceuticals Inc. For the full company profile including market capitalisation, see Vertex Pharmaceuticals Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $3.19 Billion | $3.63 Billion | $437.60 Million | ▼ -5.1% |
| 2023 | 0.93x | $3.28 Billion | $3.54 Billion | $258.40 Million | ▼ -2.5% |
| 2022 | 0.95x | $3.93 Billion | $4.13 Billion | $204.70 Million | ▲ +4.3% |
| 2021 | 0.91x | $2.41 Billion | $2.64 Billion | $235.00 Million | ▼ -1.0% |
| 2020 | 0.92x | $2.99 Billion | $3.25 Billion | $259.80 Million | ▼ -3.3% |
| 2019 | 0.95x | $1.49 Billion | $1.57 Billion | $75.45 Million | ▲ +2.9% |
| 2018 | 0.92x | $1.17 Billion | $1.27 Billion | $95.52 Million | ▲ +33.5% |
| 2017 | 0.69x | $585.52 Million | $844.94 Million | $259.42 Million | ▼ -8.9% |
| 2016 | 0.76x | $179.54 Million | $236.10 Million | $56.56 Million | ▲ +3.5% |
| 2012 | 0.73x | $196.70 Million | $267.84 Million | $71.14 Million | ▲ +114.8% |
| 2011 | 0.34x | $49.14 Million | $143.74 Million | $94.59 Million | ▼ -56.8% |
| 1993 | 0.79x | $6.80 Million | $8.60 Million | $1.80 Million | — |